
Bruce E Sands
Gastroenterology · Icahn School of Medicine at Mount Sinai
Credentials: · · ·
History
Research
Infliximab for induction and maintenance therapy for ulcerative colitis
New England Journal of Medicine · 2005 · 3,208 citations
Systematic review or meta-analysis · Gastroenterology · 2021 · 2,418 citations
Infliximab for the treatment of fistulas in patients with Crohn's disease
New England Journal of Medicine · 1999 · 2,148 citations

105 papers · 53 as a resident

93 papers
- MD
50 papers

48 papers

44 papers

43 papers · 4 as a fellow

43 papers

31 papers · 19 as a fellow
Grants
- 2026–2031
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $828.1K · University of California Los Angeles
- 2020–2025
National Center for Advancing Translational Sciences · U01
Contact PI · $4.7M · Icahn School of Medicine at Mount Sinai
- 2016
Center for Studies of Inflammatory Bowel Disease (CSIBD)
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $581.1K · Massachusetts General Hospital
- 2007–2011
OSCCAR: A Novel, Population-Based Prospective Inception Cohort of Inflammatory Bo
National Institute of Diabetes and Digestive and Kidney Diseases · R21
Contact PI · $447.8K · Icahn School of Medicine at Mount Sinai
Clinical trials
- 2023–2025
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Principal investigator · Completed · Phase 3
Abivax S.A.
- 2023–2030
- 2022–2025
Principal investigator · Completed
Icahn School of Medicine at Mount Sinai
- 2016–2018
Corticosteroids With Vedolizumab in Crohn's Disease
Principal investigator · Terminated · Phase 4
Icahn School of Medicine at Mount Sinai




